Studies of the effects of 1,25-dihydroxyvitamin D on skeletal and calcium homeostasis and on inhibition of tumor cell growth

This publication has 17 references indexed in Scilit:

• Mitogen-activated protein kinase inhibits 1,25-dihydroxyvitamin D3–dependent signal transduction by phosphorylating human retinoid X receptor α
  Journal of Clinical Investigation, 1999
• Vitamin D3 differentially regulates parathyroid hormone/parathyroid hormone-related peptide receptor expression in bone and cartilage
  Journal of Clinical Investigation, 1999
• The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties Revealed
  Journal of Bone and Mineral Research, 1998
• Cell-Specific Expression of the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Gene in Kidney from Kidney-Specific and Ubiquitous Promoters
  Endocrinology, 1997
• Vitamin D Receptor in Endometrial Carcinoma and the Differentiation‐Inducing Effect of 1,25‐Dihydroxyvitamin D₃ on Endometrial Carcinoma Cell Lines
  Journal of Obstetrics and Gynaecology Research, 1996
• Vitamin D receptor expression is required for growth modulation by 1α,25-dihydroxyvitamin D3 in the human prostatic carcinoma cell line ALVA-31
  The Journal of Steroid Biochemistry and Molecular Biology, 1996
• Molecular cloning of the gene encoding the mouse parathyroid hormone/parathyroid hormone-related peptide receptor.
  Proceedings of the National Academy of Sciences, 1994
• A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
  Journal of Clinical Investigation, 1993
• Regulation of parathyroid hormone-like peptide in cultured normal human keratinocytes. Effect of growth factors and 1,25 dihydroxyvitamin D3 on gene expression and secretion.
  Journal of Clinical Investigation, 1991
• A Parathyroid Hormone-Related Protein Implicated in Malignant Hypercalcemia: Cloning and Expression
  Science, 1987